Full Coverage

Cell Genesys ends second of two Phase III trial for prostate cancer treatment

finanznachrichten.de
27-Aug-2008
        
Story Timeline:  99 days

NEW YORK (Thomson Financial) - Cell Genesys Inc. Wednesday said it ended the second of two Phase III trials of GVAX immunotherapy for prostate cancer. The cancellation was based on the recommendation by the Independent Data Monitoring Committee, which observed an 'imbalance of death' between the two treatment arms of the study. One arm of the study treated... [read full story]                    

Add Comment
Latest article on this story:

Cell Genesys terminates Phase III prostate cancer trial

 pharmaceutical-business-review.com 29-Aug-2008
First article on this story:

Cell Genesys slides in premarket as GVAX trials stopped after deaths

 marketwatch.com 27-Aug-2008
Selected publications with coverage of this story:
redorbit.com pharmaceutical-business-review.com ibtimes.com marketwatch.com ducknetweb.blogspot.com yahoo.com wsj.com finanznachrichten.de
RELATED
No documents found.